查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1867241

胃腸道糞便檢驗市場（按檢測類型、應用、技術、最終用戶和分銷管道分類）—2025-2032年全球預測

GI Stool Testing Market by Test Type, Application, Technology, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，胃腸道糞便檢驗市場將成長至 11.8368 億美元，複合年成長率為 6.94%。

關鍵市場統計數據
基準年 2024 6.9183億美元
預計年份：2025年 7.3952億美元
預測年份 2032 11.8368億美元
複合年成長率 (%) 6.94%

這是一篇具有前瞻性的介紹文章，闡述了技術創新、臨床應用、監管更新以及以患者為中心的檢體採集模式如何重塑胃腸道診斷。

消化器官系統糞便檢驗已從一項小眾的實驗室分析發展成為一個多元化的診斷領域，其臨床應用不斷擴展，技術也在快速進步。分子診斷和定序平台的最新進展提高了分析的敏感度和特異性，而檢體穩定技術、居家採集試劑盒和數位化結果報告方面的創新則徹底改變了臨床醫生和患者參與檢測的方式。這些變化使得更廣泛的篩檢項目、更精準的感染疾病診斷以及更豐富的微生物組分析成為可能，從而為治療決策和轉化研究提供基礎。

深入分析技術創新、臨床應用、報銷和分銷等方面的變革性變化如何重塑糞便診斷的開發和部署方式。

技術、臨床和商業性因素的共同作用，推動了糞便診斷領域的變革性轉變。即時PCR、數位PCR和等溫擴增等分子檢測方法因其快速、高精度而日益受到重視，而次世代定序技術則為深入了解微生物組和多重病原體檢測開闢了新的途徑。同時，免疫檢測仍是許多實驗室工作流程中可靠且經濟高效的選擇，尤其是在採用化學冷光免疫檢測（ELISA）或側向層析等支持分散式檢查的形式時。

對 2025 年美國關稅變化對供應鏈、製造商策略、採購選擇和診斷服務連續性的影響進行實際分析。

2025年，美國累積關稅調整為依賴跨境供應鏈的診斷設備製造商和試劑供應商帶來了新的成本促進因素。新增進口關稅選擇性地影響了設備零件、試劑原料以及用於檢體穩定和萃取流程的耗材。這些貿易措施迫使許多供應商重新評估其籌資策略，加快關鍵零件的在地採購，並調整分銷合約以降低交付風險和不確定性。

針對特定族群的細分資訊揭示了檢測類型、臨床應用、技術模式、最終用戶畫像和分銷管道選擇如何相互作用，從而影響診斷方法的採納。

市場區隔洞察揭示了糞便診斷領域臨床需求、技術能力和商業性重點的交匯點。基於檢測類型的市場分析考察了培養法、免疫檢測和聚合酵素鏈鎖反應(PCR)，每種檢測類型對臨床工作流程的影響各不相同：培養法對於全面分離病原體至關重要；免疫檢測因其快速篩檢和成本效益而備受青睞；PCR 則可實現靶向、靈敏的病原體檢測。依應用領域分類，市場分析分為三個細分市場：癌症篩檢、感染疾病和微生物組分析。這一頻譜反映了診斷重點的不斷擴展，從人群篩檢到急性感染疾病管理，再到探索主導微生物組研究。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 在糞便檢驗中，擴大採用次世代定序技術進行全面的腸道微生物組分析。
  • 開發一種整合微生物、代謝物和宿主生物標記分析的多體學胃腸道糞便糞便檢驗
  • 推出面向消費者的糞便檢驗平台，該平台與遠端醫療相結合，提供個人化的胃腸道護理。
  • 將人工智慧和機器學習演算法結合，用於糞便檢驗結果的預測分析和診斷。
  • 提高使用糞便檢驗進行非侵入性結直腸癌篩檢的監管核准和保險覆蓋範圍
  • 糞便檢測技術在發炎性腸道疾病和胃腸道感染疾病檢測的進展
  • 基於糞便微生物組分析，擴大個人化飲食和益生菌干預的建議

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依檢測方法分類的胃腸道糞便檢驗市場

  • 培養試驗
  • 免疫檢測
  • 聚合酵素鏈鎖反應

9. 按應用分類的胃腸道糞便檢驗市場

  • 癌症篩檢
  • 感染疾病
  • 微生物組分析

第10章 胃腸道糞便檢驗市場（依技術分類）

  • 免疫檢測
    • 化學冷光免疫檢測
    • ELISA
    • 側向流
  • 微陣列
  • 分子診斷
    • 數位PCR
    • 等溫擴增
    • 即時PCR
  • 次世代定序

第11章 依最終用戶分類的胃腸道糞便檢驗市場

  • 診斷實驗室
  • 醫院
  • 參考檢驗機構
  • 研究所

第12章 胃腸道糞便檢驗市場（依通路分類）

  • 直銷
  • 線上
  • 第三方經銷商

第13章 各地區的胃腸道糞便檢驗市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 胃腸道糞便檢驗市場（依群體分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國胃腸道糞便檢驗市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • Exact Sciences Corporation
    • Eurofins Scientific SE
    • F. Hoffmann-La Roche Ltd
    • Danaher Corporation
    • QIAGEN NV
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
Product Code: MRR-CB04E056547A

The GI Stool Testing Market is projected to grow by USD 1,183.68 million at a CAGR of 6.94% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 691.83 million
Estimated Year [2025] USD 739.52 million
Forecast Year [2032] USD 1,183.68 million
CAGR (%) 6.94%

A forward-looking introduction explaining how technological innovation, clinical adoption, regulatory updates, and patient-centric collection models are reshaping gastrointestinal stool diagnostics

Gastrointestinal stool testing has evolved from niche laboratory assays into a diverse diagnostic domain with expanding clinical applications and rapidly improving technologies. Recent advances in molecular diagnostics and sequencing platforms have increased analytical sensitivity and specificity, while innovations in sample stabilization, at-home collection kits, and digital result reporting have changed how clinicians and patients engage with testing pathways. These shifts are enabling broader screening programs, more precise infectious disease diagnostics, and richer microbiome analyses that inform both therapeutic decisions and translational research.

As clinical pathways adapt, regulatory frameworks and reimbursement models are responding in parallel, creating new pathways for test validation and market entry. In practice, this means laboratory directors, hospital administrators, and product teams need to integrate operational feasibility with clinical utility when selecting assays and deploying testing workflows. Moving forward, integrating multi-analyte molecular assays with immunoassays and sequencing outputs will be crucial for delivering comprehensive diagnostic insights at the point where clinical decision-making occurs.

An incisive assessment of the transformative technological, clinical adoption, reimbursement, and distribution shifts reshaping how stool diagnostics are developed and deployed

The landscape of stool diagnostics has undergone transformative shifts driven by converging technological, clinical, and commercial forces. Molecular testing modalities, including real time PCR, digital PCR, and isothermal amplification, are increasingly favored for their rapid turnaround and precision, while next generation sequencing has unlocked deeper microbiome insights and multiplex pathogen detection. In tandem, immunoassays remain a robust, cost-effective option for many laboratory workflows, particularly when configured as chemiluminescent immunoassay, Elisa, or lateral flow formats that support decentralized testing.

Clinical practice has shifted toward multiplexed and layered testing strategies that combine culture, immunoassay, and polymerase chain reaction approaches where appropriate, enabling clinicians to triage patients more effectively and reduce empirical therapy. Concurrently, payer interest in tests that demonstrably impact clinical outcomes has intensified, prompting developers to generate evidence that aligns analytical validity with clinical utility. Operationally, distribution models and online ordering platforms are accelerating access, while diagnostic laboratories and hospitals reassess laboratory capacity, reference testing partnerships, and data integration to support these transformative shifts.

A practical analysis of how recent United States tariff changes in 2025 are influencing supply chains, manufacturer strategies, procurement choices, and diagnostic service continuity

In 2025, cumulative tariff adjustments in the United States introduced new cost considerations for diagnostic manufacturers and reagent suppliers that rely on cross-border supply chains. Additional import duties have selectively affected instrument components, raw materials for reagents, and consumables used in sample stabilization and extraction workflows. These trade measures have prompted many suppliers to reassess sourcing strategies, accelerate localization of critical components, and recalibrate distribution agreements to mitigate delivery risks and timeline uncertainty.

Consequently, laboratories and procurement teams have responded by diversifying supplier bases and increasing strategic inventory for high-turnover consumables. Suppliers that maintain flexible manufacturing footprints and visible supply chain telemetry have seen improved resilience, while those dependent on specialized imported components have pursued dual-sourcing or contractual hedges. Importantly, clinical laboratories and healthcare systems are balancing short-term cost pressures with the need to preserve continuity of diagnostic services, making supplier reliability and validation support key decision criteria when selecting partners amidst evolving tariff landscapes.

Targeted segmentation intelligence revealing how test type, clinical application, technological modality, end-user profile, and distribution choices intersect to shape diagnostic adoption

Segmentation insights illuminate where clinical demand, technical capability, and commercial focus intersect across stool diagnostics. Based on Test Type, market is studied across Culture, Immunoassay, and Polymerase Chain Reaction, and each test type influences clinical workflows differently: culture remains essential for comprehensive pathogen isolation, immunoassays are valued for rapid screening and cost efficiency, and polymerase chain reaction enables targeted, high-sensitivity pathogen detection. Based on Application, market is studied across Cancer Screening, Infectious Disease, and Microbiome Analysis, and this spectrum demonstrates how diagnostic priorities extend from population-level screening to acute infectious management and exploratory microbiome-driven research.

Based on Technology, market is studied across Immunoassays, Microarrays, Molecular Diagnostics, and Next Generation Sequencing. The Immunoassays is further studied across Chemiluminescent Immunoassay, Elisa, and Lateral Flow, offering options that balance throughput, sensitivity, and decentralization. The Molecular Diagnostics is further studied across Digital PCR, Isothermal Amplification, and Real Time PCR, each offering trade-offs between quantitative precision, implementation complexity, and time-to-result. Based on End User, market is studied across Diagnostic Laboratories, Hospitals, Reference Laboratories, and Research Institutes, reflecting differing adoption drivers from routine clinical diagnostics to investigational studies. Based on Distribution Channel, market is studied across Direct Sales, Online, and Third Party Distributors, indicating how go-to-market strategies must align with buyer preferences, procurement cycles, and regulatory constraints.

Comprehensive regional perspective detailing how healthcare infrastructure, regulatory realities, and adoption drivers vary across the Americas, EMEA, and Asia-Pacific markets

Regional dynamics in gastrointestinal stool testing reflect differentiated healthcare priorities, regulatory frameworks, and infrastructure capabilities across global markets. In the Americas, investment in molecular diagnostics and centralized reference laboratory networks has driven broader clinical adoption of PCR-based infectious disease panels and advanced sequencing for microbiome studies, supported by established reimbursement pathways and robust diagnostic research ecosystems. In Europe, Middle East & Africa, heterogeneity in regulatory environments and laboratory capacity has led to a mix of decentralized immunoassay adoption and selective implementation of higher-complexity molecular assays, with cross-border collaboration and harmonized guidance increasingly shaping test validation and deployment.

In the Asia-Pacific region, rapid tech adoption, significant private-sector laboratory expansion, and government-backed screening initiatives have accelerated uptake of both point-of-care immunoassays and centralized sequencing capabilities. Across regions, infrastructural differences influence adoption timelines and preferred modalities, while cross-regional partnerships and harmonization efforts are helping to disseminate best practices for clinical validation, sample logistics, and result interoperability. For stakeholders, regional strategy must therefore balance global technology trends with local regulatory realities and laboratory capabilities.

Strategic overview of competitive positioning highlighting platform integration, evidence generation, regulatory strategy, supply chain resilience, and distribution agility

Competitive dynamics in stool diagnostics are increasingly defined by the intersection of platform breadth, evidence generation, regulatory acumen, and supply chain resilience. Leading diagnostic developers and laboratory groups are investing in integrated portfolios that combine immunoassays, molecular tests, and sequencing workflows to serve a broader set of clinical use cases and payer requirements. Strategic partnerships-ranging from reagent supply agreements to co-development arrangements with academic institutions-are accelerating the translation of research-grade microbiome insights into clinically actionable products.

Additionally, companies that offer robust validation datasets, streamlined regulatory submissions, and scalable manufacturing capacity gain preferential access to large institutional buyers and reference laboratory networks. Distribution strategy also plays a pivotal role; organizations that provide flexible procurement options, including online ordering and third party distribution networks, are better positioned to meet the needs of diverse end users. Ultimately, competitive advantage increasingly depends on the ability to demonstrate clinical utility, support implementation through training and validation, and maintain transparent, resilient supply chains.

Actionable recommendations for companies and healthcare leaders to optimize product validation, supply chain resilience, payer engagement, and go-to-market execution in stool diagnostics

Industry leaders seeking to capitalize on stool diagnostic opportunities should prioritize three interrelated actions: first, align product development and validation efforts with clear clinical endpoints that demonstrate how tests change patient management and reduce downstream costs. Second, invest in supply chain flexibility by diversifying suppliers, localizing critical component production where feasible, and instituting robust inventory and delivery monitoring to insulate operations from tariff and logistics disruptions. Third, design go-to-market strategies that reflect end-user needs across diagnostic laboratories, hospitals, reference laboratories, and research institutes, and that leverage a mix of direct sales, online channels, and third party distributors to reach diverse procurement pathways.

In addition, stakeholders should strengthen payer engagement early in clinical development to clarify evidence thresholds for reimbursement, and they should pursue interoperability standards and data integration capabilities to ensure results are actionable within electronic health records and laboratory information management systems. Finally, consider strategic partnerships with clinical networks and research consortia to accelerate real-world evidence generation and validate microbiome and cancer screening applications in representative patient populations. Taken together, these steps reduce commercial risk and enhance the probability of sustainable clinical adoption.

Transparent research methodology outlining expert interviews, literature triangulation, comparative technology assessment, and supply chain sensitivity analysis to underpin findings

This research synthesizes primary interviews, secondary literature, and analytical review to produce an evidence-driven assessment of the stool diagnostics landscape. Primary insights were derived from structured interviews with laboratory directors, clinical leaders, regulatory specialists, procurement managers, and technology developers, which informed qualitative understanding of adoption drivers, validation priorities, and operational constraints. Secondary sources included peer-reviewed clinical studies, regulatory guidance documents, and supplier technical specifications to corroborate performance characteristics and regulatory pathways for different technologies.

Analytical methods included comparative technology assessment, supply chain sensitivity analysis, and a structured mapping of clinical use cases to test modalities and end-user workflows. Where possible, validation claims and performance metrics reported by manufacturers were cross-checked against independent literature and expert feedback. Throughout the methodology, emphasis was placed on transparency of data sources and reproducibility of key analytic steps, and sensitivity considerations were used to contextualize where findings depend on evolving regulatory or reimbursement decisions.

A concise conclusion synthesizing how clinical utility, technological capability, regulatory alignment, and operational resilience will determine success in stool diagnostics

In conclusion, gastrointestinal stool testing is at an inflection point where technological maturation, shifting clinical expectations, and evolving commercial models converge. Molecular diagnostics and next generation sequencing are broadening diagnostic capabilities and enabling multipurpose applications ranging from infectious disease management to microbiome-informed research, while immunoassays continue to deliver pragmatic, high-throughput screening solutions that support decentralized care. Regulatory and reimbursement developments are increasingly important determinants of adoption, and supply chain resilience has emerged as a strategic differentiator in the wake of tariff and logistics volatility.

Moving forward, successful stakeholders will be those that align rigorous validation and evidence generation with operational readiness and flexible distribution strategies. Collaboration across clinicians, laboratory partners, and technology providers will accelerate adoption and ensure that diagnostic innovations translate into measurable improvements in patient care. In short, integrated approaches that balance clinical utility, implementation feasibility, and commercial agility will define success in this rapidly evolving diagnostic category.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of next-generation sequencing technologies for comprehensive gut microbiome profiling in stool tests
  • 5.2. Development of multi-omics gastrointestinal stool tests integrating microbial, metabolite, and host biomarker analysis
  • 5.3. Emergence of direct-to-consumer at-home stool testing platforms linked with telemedicine for personalized gastrointestinal care
  • 5.4. Integration of artificial intelligence and machine learning algorithms for predictive analysis of stool test results and diagnostics
  • 5.5. Growing regulatory approvals and expanded reimbursement for noninvasive colorectal cancer screening using stool-based tests
  • 5.6. Advancements in stool-based diagnostics for inflammatory bowel disease and gastrointestinal infection detection
  • 5.7. Expansion of personalized dietary and probiotic intervention recommendations driven by stool microbiome analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. GI Stool Testing Market, by Test Type

  • 8.1. Culture
  • 8.2. Immunoassay
  • 8.3. Polymerase Chain Reaction

9. GI Stool Testing Market, by Application

  • 9.1. Cancer Screening
  • 9.2. Infectious Disease
  • 9.3. Microbiome Analysis

10. GI Stool Testing Market, by Technology

  • 10.1. Immunoassays
    • 10.1.1. Chemiluminescent Immunoassay
    • 10.1.2. Elisa
    • 10.1.3. Lateral Flow
  • 10.2. Microarrays
  • 10.3. Molecular Diagnostics
    • 10.3.1. Digital PCR
    • 10.3.2. Isothermal Amplification
    • 10.3.3. Real Time PCR
  • 10.4. Next Generation Sequencing

11. GI Stool Testing Market, by End User

  • 11.1. Diagnostic Laboratories
  • 11.2. Hospitals
  • 11.3. Reference Laboratories
  • 11.4. Research Institutes

12. GI Stool Testing Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Online
  • 12.3. Third Party Distributors

13. GI Stool Testing Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. GI Stool Testing Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. GI Stool Testing Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Laboratory Corporation of America Holdings
    • 16.3.2. Quest Diagnostics Incorporated
    • 16.3.3. Exact Sciences Corporation
    • 16.3.4. Eurofins Scientific SE
    • 16.3.5. F. Hoffmann-La Roche Ltd
    • 16.3.6. Danaher Corporation
    • 16.3.7. QIAGEN N.V.
    • 16.3.8. Bio-Rad Laboratories, Inc.
    • 16.3.9. Thermo Fisher Scientific Inc.
    • 16.3.10. Abbott Laboratories

LIST OF FIGURES

  • FIGURE 1. GLOBAL GI STOOL TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GI STOOL TESTING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL GI STOOL TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GI STOOL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL GI STOOL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL GI STOOL TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS GI STOOL TESTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL GI STOOL TESTING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. GI STOOL TESTING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. GI STOOL TESTING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. GI STOOL TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL GI STOOL TESTING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL GI STOOL TESTING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL GI STOOL TESTING MARKET SIZE, BY CULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL GI STOOL TESTING MARKET SIZE, BY CULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL GI STOOL TESTING MARKET SIZE, BY CULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL GI STOOL TESTING MARKET SIZE, BY CULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL GI STOOL TESTING MARKET SIZE, BY CULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL GI STOOL TESTING MARKET SIZE, BY CULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL GI STOOL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL GI STOOL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL GI STOOL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL GI STOOL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL GI STOOL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL GI STOOL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL GI STOOL TESTING MARKET SIZE, BY CANCER SCREENING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL GI STOOL TESTING MARKET SIZE, BY CANCER SCREENING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL GI STOOL TESTING MARKET SIZE, BY CANCER SCREENING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL GI STOOL TESTING MARKET SIZE, BY CANCER SCREENING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL GI STOOL TESTING MARKET SIZE, BY CANCER SCREENING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL GI STOOL TESTING MARKET SIZE, BY CANCER SCREENING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL GI STOOL TESTING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL GI STOOL TESTING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL GI STOOL TESTING MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL GI STOOL TESTING MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL GI STOOL TESTING MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL GI STOOL TESTING MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL GI STOOL TESTING MARKET SIZE, BY MICROBIOME ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL GI STOOL TESTING MARKET SIZE, BY MICROBIOME ANALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL GI STOOL TESTING MARKET SIZE, BY MICROBIOME ANALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL GI STOOL TESTING MARKET SIZE, BY MICROBIOME ANALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL GI STOOL TESTING MARKET SIZE, BY MICROBIOME ANALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL GI STOOL TESTING MARKET SIZE, BY MICROBIOME ANALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL GI STOOL TESTING MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL GI STOOL TESTING MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL GI STOOL TESTING MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL GI STOOL TESTING MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL GI STOOL TESTING MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL GI STOOL TESTING MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL GI STOOL TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL GI STOOL TESTING MARKET SIZE, BY ELISA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL GI STOOL TESTING MARKET SIZE, BY ELISA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL GI STOOL TESTING MARKET SIZE, BY ELISA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL GI STOOL TESTING MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL GI STOOL TESTING MARKET SIZE, BY ELISA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL GI STOOL TESTING MARKET SIZE, BY LATERAL FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL GI STOOL TESTING MARKET SIZE, BY LATERAL FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL GI STOOL TESTING MARKET SIZE, BY LATERAL FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL GI STOOL TESTING MARKET SIZE, BY LATERAL FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL GI STOOL TESTING MARKET SIZE, BY LATERAL FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL GI STOOL TESTING MARKET SIZE, BY LATERAL FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL GI STOOL TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL GI STOOL TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL GI STOOL TESTING MARKET SIZE, BY MICROARRAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL GI STOOL TESTING MARKET SIZE, BY MICROARRAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL GI STOOL TESTING MARKET SIZE, BY MICROARRAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL GI STOOL TESTING MARKET SIZE, BY MICROARRAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL GI STOOL TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL GI STOOL TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL GI STOOL TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL GI STOOL TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL GI STOOL TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL GI STOOL TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL GI STOOL TESTING MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL GI STOOL TESTING MARKET SIZE, BY REAL TIME PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL GI STOOL TESTING MARKET SIZE, BY REAL TIME PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL GI STOOL TESTING MARKET SIZE, BY REAL TIME PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL GI STOOL TESTING MARKET SIZE, BY REAL TIME PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL GI STOOL TESTING MARKET SIZE, BY REAL TIME PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL GI STOOL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL GI STOOL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL GI STOOL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL GI STOOL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL GI STOOL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL GI STOOL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL GI STOOL TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL GI STOOL TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL GI STOOL TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL GI STOOL TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL GI STOOL TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL GI STOOL TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL GI STOOL TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL GI STOOL TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL GI STOOL TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL GI STOOL TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL GI STOOL TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL GI STOOL TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL GI STOOL TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL GI STOOL TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL GI STOOL TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL GI STOOL TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL GI STOOL TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL GI STOOL TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL GI STOOL TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL GI STOOL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL GI STOOL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL GI STOOL TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL GI STOOL TESTING MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL GI STOOL TESTING MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL GI STOOL TESTING MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL GI STOOL TESTING MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL GI STOOL TESTING MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL GI STOOL TESTING MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL GI STOOL TESTING MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL GI STOOL TESTING MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL GI STOOL TESTING MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL GI STOOL TESTING MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL GI STOOL TESTING MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL GI STOOL TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL GI STOOL TESTING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS GI STOOL TESTING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS GI STOOL TESTING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS GI STOOL TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS GI STOOL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS GI STOOL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA GI STOOL TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA GI STOOL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA GI STOOL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA GI STOOL TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA GI STOOL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA GI STOOL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE GI STOOL TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE GI STOOL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE GI STOOL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
  • TABLE 248. MIDDLE EAST GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 250. MIDDLE EAST GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST GI STOOL TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST GI STOOL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 254. MIDDLE EAST GI STOOL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 263. AFRICA GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
  • TABLE 264. AFRICA GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2032 (USD MILLION)
  • TABLE 265. AFRICA GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 266. AFRICA GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 267. AFRICA GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. AFRICA GI STOOL TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. AFRICA GI STOOL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 270. AFRICA GI STOOL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL GI STOOL TESTING MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL GI STOOL TESTING MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. ASEAN GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. ASEAN GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. ASEAN GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. ASEAN GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 296. ASEAN GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 297. ASEAN GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
  • TABLE 298. ASEAN GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2032 (USD MILLION)
  • TABLE 299. ASEAN GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 300. ASEAN GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 301. ASEAN GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 302. ASEAN GI STOOL TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 303. ASEAN GI STOOL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 304. ASEAN GI STOOL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 305. GCC GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. GCC GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. GCC GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. GCC GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. GCC GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. GCC GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. GCC GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 312. GCC GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 313. GCC GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
  • TABLE 314. GCC GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2032 (USD MILLION)
  • TABLE 315. GCC GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 316. GCC GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 317. GCC GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 318. GCC GI STOOL TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 319. GCC GI STOOL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 320. GCC GI STOOL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPEAN UNION GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPEAN UNION GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPEAN UNION GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPEAN UNION GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 325. EUROPEAN UNION GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 326. EUROPEAN UNION GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 327. EUROPEAN UNION GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 328. EUROPEAN UNION GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 329. EUROPEAN UNION GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
  • TABLE 330. EUROPEAN UNION GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2032 (USD MILLION)
  • TABLE 331. EUROPEAN UNION GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 332. EUROPEAN UNION GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 333. EUROPEAN UNION GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 334. EUROPEAN UNION GI STOOL TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 335. EUROPEAN UNION GI STOOL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 336. EUROPEAN UNION GI STOOL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 337. BRICS GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (U